Refludan [lepirudin (rDNA) for injection] Protect life and limb

Learn more about the benefits of REFLUDAN
This section contains REFLUDAN laboratory and clinical efficacy data
This section contains information regarding the safe administration of REFLUDAN for the treatment of heparin induced thrombocytopenia (HIT)
This section describes the dosage and administration of REFLUDAN in the treatment of heparin induced thrombocytopenia (HIT)
Heparin induced thrombocytopenia
A summary of pivotal trial data for REFLUDAN is covered in this section
This section provides access to a variety of resources to obtain in-depth information on heparin induced thrombocytopenia (HIT) and REFLUDAN
Find out what your peers are saying about heparin induced thrombocytopenia (HIT)...

©2007 Bayer Healthcare Pharmaceuticals Inc. All rights reserved.
H.I.T. BACK with REFLUDAN to protect life and limb
Who treats HIT most frequently in your facility?



Cardiologist     15%
Hematologist     41%
Intensivist     12%
Internist     7%
Surgeon     7%
Other     15%

Would you like to participate in this survey?   Go!

Terms of Use      Privacy Policy      About Our New Company
Bayer Healthcare Pharmaceuticals